Insider Transactions in Q3 2024 at Ligand Pharmaceuticals Inc (LGND)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2024
|
Andrew Reardon CLO & Secretary |
SELL
Open market or private sale
|
Direct |
2,000
-8.15%
|
$198,000
$99.6 P/Share
|
|
Sep 23
2024
|
Andrew Reardon CLO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+7.54%
|
$104,000
$52.27 P/Share
|
|
Sep 23
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
9,772
-5.57%
|
$986,972
$101.24 P/Share
|
|
Sep 23
2024
|
Matthew E Korenberg President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,772
+7.09%
|
$498,372
$51.42 P/Share
|
|
Sep 20
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
6,275
-11.0%
|
$652,600
$104.1 P/Share
|
|
Sep 20
2024
|
Matthew E Korenberg President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,982
+8.03%
|
$244,118
$49.99 P/Share
|
|
Sep 20
2024
|
Octavio Espinoza Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,275
-1.66%
|
$131,325
$103.93 P/Share
|
|
Sep 17
2024
|
Octavio Espinoza Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,486
+2.73%
|
$101,048
$68.97 P/Share
|
|
Sep 16
2024
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,214
-1.53%
|
$337,470
$105.0 P/Share
|
|
Sep 16
2024
|
Matthew E Korenberg President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,774
+2.64%
|
$323,344
$56.29 P/Share
|
|
Aug 28
2024
|
Octavio Espinoza Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
753
+1.52%
|
$47,439
$63.63 P/Share
|
|
Aug 28
2024
|
Andrew Reardon CLO & Secretary |
SELL
Open market or private sale
|
Direct |
1,500
-6.24%
|
$159,000
$106.39 P/Share
|
|
Aug 28
2024
|
Andrew Reardon CLO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+5.87%
|
$78,000
$52.27 P/Share
|
|
Aug 26
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
11,389
-9.83%
|
$1,195,845
$105.67 P/Share
|
|
Aug 23
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
6,312
-4.8%
|
$656,448
$104.61 P/Share
|
|
Aug 22
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
1,157
-1.69%
|
$121,485
$105.54 P/Share
|
|
Aug 09
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
18,245
-21.07%
|
$1,788,010
$98.5 P/Share
|
|
Aug 08
2024
|
Todd C Davis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+1.99%
|
$242,500
$97.39 P/Share
|